Profile
Fei Jiang currently holds the position of Non-Executive Director at Tyligand Bioscience Ltd. starting in 2026.
Dr. Jiang is also a Non-Executive Director at Eastenova (Chengdu) Biotechnology Co., Ltd. since 2025.
Additionally, Dr. Jiang has been the Chief Investment Officer-Greater China at China Medical System Holdings Ltd. since 2022.
Dr. Jiang earned a doctorate from Syracuse University in 2006 and an undergraduate degree from East China University of Science & Technology in 1998.
Fei Jiang active positions
| Companies | Position | Start |
|---|---|---|
| CHINA MEDICAL SYSTEM HOLDINGS LIMITED | Chief Investment Officer | 2021-12-31 |
Tyligand Bioscience Ltd
Tyligand Bioscience Ltd BiotechnologyHealth Technology Engages in discovery and development of cancer therapeutics | Director/Board Member | 2024-03-31 |
Training of Fei Jiang
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Syracuse University
Syracuse University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
China Medical System Holdings Ltd.
China Medical System Holdings Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes prescription drugs and pharmaceutical products | Health Technology |
East China University of Science & Technology
East China University of Science & Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tyligand Bioscience Ltd
Tyligand Bioscience Ltd BiotechnologyHealth Technology Engages in discovery and development of cancer therapeutics | Health Technology |
- Stock Market
- Insiders
- Fei Jiang
















